Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Euronext Growth Paris  >  Theranexus    ALTHX   FR0013286259

THERANEXUS

(ALTHX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Theranexus specializes in the research and development of therapeutic products for the treatment of diseases affecting the central nervous system.

At the end of 2019, the group had a portfolio of 3 products in clinical development phase, including 1 in phase II (THN102; treatment of narcolepsy-related sleep-wake disorders and Parkinson's disease) and 2 in phase I (THN101 for the treatment of neuropathic pain and THN201 for the treatment of neurocognitive disorders in Alzheimer's disease).

Number of employees : 18 people.
Managers
NameAgeSinceTitle
Franck Joseph Louis Mouthon-2013Chairman & Chief Executive Officer
Thierry Bertrand Lambert--Chief Financial & Administrative Officer
Mathieu Bernard Mari Charveriat, Dr.-2013Director, Chief Scientific Officer & Deputy CEO
Werner Rein, Dr.-2017Chief Medical Officer
Dominique Costantini, Dr.-2017Independent Director
Luc-André Granier, Dr.-2017Independent Director
Florian Denis-2017Director
Jérôme Martinez, Dr.582018Independent Director
Rodolphe Besserve-2018Independent Director
Julien Veys-2016Chief Business Development Officer
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 3,622,413 2,077,991 57.4% 0 0.0% 57.4%
Shareholders
NameEquities%
Ostrum Asset Management SA 169,009 4.67%
Norges Bank Investment Management 91,899 2.54%
Keren Finance SAS 24,186 0.67%
Gestys SA 14,500 0.40%
Claresco Finance SA 1,000 0.028%
Markets and indexes
- PEA / SRD eligible : YES / NO
-
- Euronext Growth Paris
- Euronext Growth All-Share / Next Biotech, PEA, PEA-PME
Stock Exchange Codes
- Bloomberg Code :  ALTHX:FR
- Reuters Code :  ALTHX.PA
- Datastream Code :  
Company contact information
Theranexus
Pépinière Laennec 60 Avenue Rockefeller
FR-69008 Lyon


Phone : +33 (0)1 46 54 98 96
Fax :
web site : https://www.theranexus.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Theranexus
Sector Bio Therapeutic Drugs
1st jan.Capitalization (M$)
THERANEXUS472.37%77
GILEAD SCIENCES, INC.-6.63%76 052
VERTEX PHARMACEUTICALS4.02%59 224
REGENERON PHARMACEUTICALS37.43%54 464
WUXI APPTEC CO., LTD.57.04%38 135
BIONTECH SE266.71%29 915
GENMAB A/S61.59%25 135
BEIGENE, LTD.54.25%23 307
ARGENX SE66.57%13 534
MYOKARDIA, INC.208.58%11 993
MIRATI THERAPEUTICS, INC.84.58%11 959
HUALAN BIOLOGICAL ENGINEERING INC.59.18%11 938
SAREPTA THERAPEUTICS, INC.9.16%11 116
ASCENDIS PHARMA A/S21.28%9 013
NEUROCRINE BIOSCIENCES, INC.-11.10%8 870
ULTRAGENYX PHARMACEUTICAL INC.177.55%7 842
DENALI THERAPEUTICS INC.250.00%7 311
ACCELERON PHARMA INC.122.69%7 114
KODIAK SCIENCES INC.89.95%6 884
BIOCON LIMITED46.19%6 874
ARROWHEAD PHARMACEUTICALS, INC.-1.42%6 425